Article Text


FRI0101 Antiribosomal-p protein antibodies in systemic lupus erythematosus patients
  1. S Päi,
  2. R Birkenfeldt
  1. Department of Internal Medicine, University of Tartu, Estonia, Tartu, Estonia


Background Autoantibodies to ribosomal-P protein (anti-P antibodies) are predominantly found in sera of patients with systemic lupus erythematosus (SLE) and have been correlated with neuropsychiatric lupus in some but not all studies.1 The frequency of anti-P antibodies in SLE population can vary from 6% to 36% in different ethnic groups.2

Objectives To clarify the frequency of presence of anti-P antibodies in patients with SLE.

Methods The investigated group constituted of 36 SLE patients (age 21–52 years, SLE duration 0.5–16 years), sera from 5 patients with discoid lupus and 48 RA patients were tested too. Sera of 20 normal healthy persons were used as normal controls. Anti-P antibodies were measured by immunoblot (INNO™ANA, Innogenetics, Belgium) and ELISA (ABP Diagnostics Inc., Canada) using commercial kits.

Results Anti-P antibodies were found in 5/36 (13.9%) SEL patients, using immunoblot, and in 7/36 (19.4%) SEL patients, using ELISA, and in 1/48 RA patient (2.1%) using ELISA. None of the sera of the other RA patients as well as discoid patients and normal persons was found to be positive for anti-P antibodies. Anti-P antibodies were occurred together with ANA, dsDNA and histone antibodies (p < 0.0001). No clinical differences were found in patients with anti-P antibodies, belonging anti-SmB and anti-SmD positive and negative groups. Among the investigated patients neurological disorders were seen only in two patients, while no studied patient had lupus psychosis. One patient had encephalomeningitis (positive anti-P antibodies by both methods) the other had APS with thrombosis (positive anti-P antibodies by ELISA). In our study all SLE patients with anti-P antibodies had active lupus nephritis (p < 0.0001), LE cells (p < 0.0001) and cardiac disorders (p > 0.05). The majority (6 from 7 patients) of these patients had polyarthritis. None of the patients with SLE duration less than 3 years had anti-P antibodies. Disease duration was longer in patients positive for anti-P antibodies (4.30 ± 5.03 and 10.10 ± 6.05 years, accordingly; p < 0.043).

Conclusion The clinical significance of presence of anti-P antibodies in SLE is limited. Presence of these antibodies is associated with acute lupus nephritis; the antibodies are found in patients with long disease duration.


  1. Teh L-S, Isenberg DA. Antiribosomal P protein antibodies in systemic lupus erythematosus. A reappraisal. Arthritis Rheum. 1994;37:307–15

  2. Arnett FC, Reveille JD, Moutsopoulos HM, Georgesen L, Elkon KB. Ribosomal P antibodies in systemic lupus erythematosus. Arthritis Rheum. 1996;39:1833–9

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.